Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |